Advertisement

Topics

Amplyx Pharmaceuticals Raises $67M to Continue Development of Antifungal Candidate

13:54 EDT 2 Aug 2017 | Drug Discovery Development

Amplyx will use the proceeds of the financing to advance the clinical development of APX001.
Contributed Author: 
Amplyx Pharmaceuticals
Topics: 

Original Article: Amplyx Pharmaceuticals Raises $67M to Continue Development of Antifungal Candidate

NEXT ARTICLE

More From BioPortfolio on "Amplyx Pharmaceuticals Raises $67M to Continue Development of Antifungal Candidate"

Quick Search
Advertisement